Gastrointestinal motility disorders in inflammatory bowel diseases

Gabrio Bassotti, Elisabetta Antonelli, Vincenzo Villanacci, Marianna Salemme, Manuela Coppola, Vito Annese, Gabrio Bassotti, Elisabetta Antonelli, Vincenzo Villanacci, Marianna Salemme, Manuela Coppola, Vito Annese

Abstract

The relationship between motility and inflammatory gastrointestinal disorders is at the same time complex and intriguing since these conditions might share some genetic, environmental, immunological and microbial predisposing factors. In addition, significant symptom overlapping may occur, muddling the waters within the clinical context. Although on one hand this represents a challenge for the clinician for a potential under- or over-treatment and diagnostic delay, on the other hand it possibly represents an opportunity for the researcher to better disclose the intimate relationship between chronic (often low-grade) inflammation, motor disorders and deranged sensory function. The best example is probably represented by Crohn's disease and ulcerative colitis. In fact, a number of gastrointestinal motor disorders have been described in association with these diseases, disorders which span from the esophagus to the anorectum, and which will be extensively covered in this review. It is conceivable that at least part of this derangement is strictly related to inflammatory cytokine trafficking and neuromuscular changes; however, given the high prevalence of functional gastrointestinal disorders in the general population, this overlap might also be serendipitous. However, it is worth noting that literature data on this topic are relatively scarce, sometimes quite outdated, and mostly focused on the interplay between irritable bowel syndrome and inflammatory bowel disease. Nevertheless, both researchers and clinicians must be aware that symptoms related to gastrointestinal motility disorders may be highly prevalent in both active and inactive inflammatory bowel disease, correlate with greater psychological comorbidity and poorer quality of life, and may negatively influence the therapeutic approaches.

Keywords: Crohn’s disease; Gastrointestinal motility disorders; Gut; Inflammatory bowel diseases; Perception; Ulcerative colitis.

References

    1. Ng SC, Bernstein CN, Vatn MH, Lakatos PL, Loftus EV, Tysk C, O’Morain C, Moum B, Colombel JF. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013;62:630–649.
    1. Fiocchi C. Genes and ‘in-vironment’: how will our concepts on the pathophysiology of inflammatory bowel disease develop in the future? Dig Dis. 2012;30 Suppl 3:2–11.
    1. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377–1390.
    1. Mitchell CM, Drossman DA. Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology. 1987;92:1282–1284.
    1. Bruley des Varannes S, Chevalier J, Pimont S, Le Neel JC, Klotz M, Schafer KH, Galmiche JP, Neunlist M. Serum from achalasia patients alters neurochemical coding in the myenteric plexus and nitric oxide mediated motor response in normal human fundus. Gut. 2006;55:319–326.
    1. Villanacci V, Annese V, Cuttitta A, Fisogni S, Scaramuzzi G, De Santo E, Corazzi N, Bassotti G. An immunohistochemical study of the myenteric plexus in idiopathic achalasia. J Clin Gastroenterol. 2010;44:407–410.
    1. Kindt S, Tertychnyy A, de Hertogh G, Geboes K, Tack J. Intestinal immune activation in presumed post-infectious functional dyspepsia. Neurogastroenterol Motil. 2009;21:832–e56.
    1. Walker MM, Salehian SS, Murray CE, Rajendran A, Hoare JM, Negus R, Powell N, Talley NJ. Implications of eosinophilia in the normal duodenal biopsy - an association with allergy and functional dyspepsia. Aliment Pharmacol Ther. 2010;31:1229–1236.
    1. Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol. 2010;7:163–173.
    1. Bassotti G, Villanacci V, Maurer CA, Fisogni S, Di Fabio F, Cadei M, Morelli A, Panagiotis T, Cathomas G, Salerni B. The role of glial cells and apoptosis of enteric neurones in the neuropathology of intractable slow transit constipation. Gut. 2006;55:41–46.
    1. Bassotti G, Villanacci V, Nascimbeni R, Cadei M, Manenti S, Antonelli E, Fanini L, Salerni B. Increase of colonic mast cells in obstructed defecation and their relationship with enteric glia. Dig Dis Sci. 2012;57:65–71.
    1. Villanacci V, Bassotti G, Nascimbeni R, Antonelli E, Cadei M, Fisogni S, Salerni B, Geboes K. Enteric nervous system abnormalities in inflammatory bowel diseases. Neurogastroenterol Motil. 2008;20:1009–1016.
    1. Bassotti G, Villanacci V, Nascimbeni R, Cadei M, Fisogni S, Antonelli E, Corazzi N, Salerni B. Enteric neuroglial apoptosis in inflammatory bowel diseases. J Crohns Colitis. 2009;3:264–270.
    1. Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2012;107:1474–1482.
    1. Keohane J, O’Mahony C, O’Mahony L, O’Mahony S, Quigley EM, Shanahan F. Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation? Am J Gastroenterol. 2010;105:1788, 1789–1794; quiz 1795.
    1. Bryant RV, van Langenberg DR, Holtmann GJ, Andrews JM. Functional gastrointestinal disorders in inflammatory bowel disease: impact on quality of life and psychological status. J Gastroenterol Hepatol. 2011;26:916–923.
    1. Kim ES, Cho KB, Park KS, Jang BI, Kim KO, Jeon SW, Jung MK, Kim EY, Yang CH. Predictive factors of impaired quality of life in Korean patients with inactive inflammatory bowel disease: association with functional gastrointestinal disorders and mood disorders. J Clin Gastroenterol. 2013;47:e38–e44.
    1. Porter CK, Cash BD, Pimentel M, Akinseye A, Riddle MS. Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome. BMC Gastroenterol. 2012;12:55.
    1. Ramaswamy K, Jacobson K, Jevon G, Israel D. Esophageal Crohn disease in children: a clinical spectrum. J Pediatr Gastroenterol Nutr. 2003;36:454–458.
    1. Lazarev M, Huang C, Bitton A, Cho JH, Duerr RH, McGovern DP, Proctor DD, Regueiro M, Rioux JD, Schumm PP, et al. Relationship between proximal Crohn’s disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics Consortium. Am J Gastroenterol. 2013;108:106–112.
    1. Hummel TZ, ten Kate FJ, Reitsma JB, Benninga MA, Kindermann A. Additional value of upper GI tract endoscopy in the diagnostic assessment of childhood IBD. J Pediatr Gastroenterol Nutr. 2012;54:753–757.
    1. Turner D, Griffiths AM. Esophageal, gastric, and duodenal manifestations of IBD and the role of upper endoscopy in IBD diagnosis. Curr Gastroenterol Rep. 2009;11:234–237.
    1. Knoblauch C, Netzer P, Scheurer U, Seibold F. Dysphagia in Crohn’s disease: a diagnostic challenge. Dig Liver Dis. 2002;34:660–664.
    1. Usai P, Bassotti G, Usai Satta P, Cherchi M, Plesa A, Boy F, Morelli A, Balestrieri A. Oesophageal motility in adult coeliac disease. Neurogastroenterol Motil. 1995;7:239–244.
    1. Katz J, Shenkman A, Stavropoulos F, Melzer E. Oral signs and symptoms in relation to disease activity and site of involvement in patients with inflammatory bowel disease. Oral Dis. 2003;9:34–40.
    1. Barratt SM, Leeds JS, Robinson K, Shah PJ, Lobo AJ, McAlindon ME, Sanders DS. Reflux and irritable bowel syndrome are negative predictors of quality of life in coeliac disease and inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2011;23:159–165.
    1. Annunziata ML, Caviglia R, Papparella LG, Cicala M. Upper gastrointestinal involvement of Crohn’s disease: a prospective study on the role of upper endoscopy in the diagnostic work-up. Dig Dis Sci. 2012;57:1618–1623.
    1. Zeng Z, Zhu Z, Yang Y, Ruan W, Peng X, Su Y, Peng L, Chen J, Yin Q, Zhao C, et al. Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: a prospective population-based study. J Gastroenterol Hepatol. 2013;28:1148–1153.
    1. Danelius M, Ost A, Lapidus AB. Inflammatory bowel disease-related lesions in the duodenal and gastric mucosa. Scand J Gastroenterol. 2009;44:441–445.
    1. Madore P, Glay A, Kahn DS. Lesions of the gastrointestinal tract resembling regional enteritis--a granulomatous disease: a report of three cases. Can Med Assoc J. 1963;89:1165–1170.
    1. Gryboski JD, Burger J, McCallum R, Lange R. Gastric emptying in childhood inflammatory bowel disease: nutritional and pathologic correlates. Am J Gastroenterol. 1992;87:1148–1153.
    1. Grill BB, Lange R, Markowitz R, Hillemeier AC, McCallum RW, Gryboski JD. Delayed gastric emptying in children with Crohn’s disease. J Clin Gastroenterol. 1985;7:216–226.
    1. Rao SS, Read NW. Gastrointestinal motility in patients with ulcerative colitis. Scand J Gastroenterol Suppl. 1990;172:22–28.
    1. Dew MJ, Harries AD, Rhodes M, Rhodes J, Leach KG. Gastric emptying after intestinal resection in Crohn’s disease. Br J Surg. 1983;70:92–93.
    1. Annese V, Bassotti G, Napolitano G, Frusciante V, Bruno M, Conoscitore P, Germani U, Morelli A, Andriulli A. Gastric emptying of solids in patients with nonobstructive Crohn’s disease is sometimes delayed. J Clin Gastroenterol. 1995;21:279–282.
    1. Keller J, Beglinger C, Holst JJ, Andresen V, Layer P. Mechanisms of gastric emptying disturbances in chronic and acute inflammation of the distal gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol. 2009;297:G861–G868.
    1. Navaneethan U, Shen B. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflamm Bowel Dis. 2010;16:1598–1619.
    1. Ledeboer M, Masclee AA, Biemond I, Lamers CB. Gallbladder motility and cholecystokinin secretion during continuous enteral nutrition. Am J Gastroenterol. 1997;92:2274–2279.
    1. Vu MK, Gielkens HA, van Hogezand RA, van Oostayen JA, Lamers CB, Masclee AA. Gallbladder motility in Crohn disease: influence of disease localization and bowel resection. Scand J Gastroenterol. 2000;35:1157–1162.
    1. Lin J, Shen B, Lee HJ, Goldblum JR. Histopathological characterization of cholecystectomy specimens in patients with inflammatory bowel disease. J Crohns Colitis. 2012;6:895–899.
    1. Hutchinson R, Tyrrell PN, Kumar D, Dunn JA, Li JK, Allan RN. Pathogenesis of gall stones in Crohn’s disease: an alternative explanation. Gut. 1994;35:94–97.
    1. Annese V, Bassotti G, Napolitano G, Betti C, Perri F, Usai P, Morelli A, Andriulli A, Vantrappen G. Most patients with inactive crohns-disease have gastrointestinal motility disorders. Gastroenterology. 1993;104(suppl):A470.
    1. Annese V, Vantrappen G. Gall stones in Crohn’s disease: another hypothesis. Gut. 1994;35:1676.
    1. Rubenstein J, Sherif A, Appelman H, Chey WD. Ulcerative colitis associated enteritis: is ulcerative colitis always confined to the colon? J Clin Gastroenterol. 2004;38:46–51.
    1. Al-Saffar A, Hellström PM. Contractile responses to natural tachykinins and selective tachykinin analogs in normal and inflamed ileal and colonic muscle. Scand J Gastroenterol. 2001;36:485–493.
    1. Peuhkuri K, Vapaatalo H, Korpela R. Even low-grade inflammation impacts on small intestinal function. World J Gastroenterol. 2010;16:1057–1062.
    1. Straub RH, Antoniou E, Zeuner M, Gross V, Schölmerich J, Andus T. Association of autonomic nervous hyperreflexia and systemic inflammation in patients with Crohn’s disease and ulcerative colitis. J Neuroimmunol. 1997;80:149–157.
    1. Ananthakrishnan AN, Issa M, Barboi A, Jaradeh S, Zadvornova Y, Skaros S, Johnson K, Otterson MF, Binion DG. Impact of autonomic dysfunction on inflammatory bowel disease. J Clin Gastroenterol. 2010;44:272–279.
    1. Farrokhyar F, Marshall JK, Easterbrook B, Irvine EJ. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis. 2006;12:38–46.
    1. Jonefjäll B, Strid H, Ohman L, Svedlund J, Bergstedt A, Simren M. Characterization of IBS-like symptoms in patients with ulcerative colitis in clinical remission. Neurogastroenterol Motil. 2013;25:756–e578.
    1. Camilleri M, Lasch K, Zhou W. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012;303:G775–G785.
    1. Kellow JE, Eckersley GM, Jones M. Enteric and central contributions to intestinal dysmotility in irritable bowel syndrome. Dig Dis Sci. 1992;37:168–174.
    1. Serra J, Villoria A, Azpiroz F, Lobo B, Santos J, Accarino A, Malagelada JR. Impaired intestinal gas propulsion in manometrically proven dysmotility and in irritable bowel syndrome. Neurogastroenterol Motil. 2010;22:401–406, e91-2.
    1. Lee OY. Asian motility studies in irritable bowel syndrome. J Neurogastroenterol Motil. 2010;16:120–130.
    1. Berrill JW, Green JT, Hood K, Campbell AK. Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity. Aliment Pharmacol Ther. 2013;38:44–51.
    1. Lahiff C, Safaie P, Awais A, Akbari M, Gashin L, Sheth S, Lembo A, Leffler D, Moss AC, Cheifetz AS. The Crohn’s disease activity index (CDAI) is similarly elevated in patients with Crohn’s disease and in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2013;37:786–794.
    1. Abraham BP, Kane S. Fecal markers: calprotectin and lactoferrin. Gastroenterol Clin North Am. 2012;41:483–495.
    1. Stryker SJ, Borody TJ, Phillips SF, Kelly KA, Dozois RR, Beart RW. Motility of the small intestine after proctocolectomy and ileal pouch-anal anastomosis. Ann Surg. 1985;201:351–356.
    1. Pescatori M. Myoelectric and motor activity of the terminal ileum after pelvic pouch for ulcerative colitis. Dis Colon Rectum. 1985;28:246–253.
    1. Chaussade S, Merite F, Hautefeuille M, Valleur P, Hautefeuille P, Couturier D. Motility of the jejunum after proctocolectomy and ileal pouch anastomosis. Gut. 1989;30:371–375.
    1. Bassotti G, Castagnoli G, Trancanelli V, Pelli MA, Morelli A. Patients with ileal pouch-anal anastomosis display contractile abnormalities of the reservoir and of the upper ileum. Dig Surg. 1991;8:10–14.
    1. Miedema BW, Karlstrom L, Hanson RB, Johnson GP, Kelly KA. Absorption and motility of the bypassed human ileum. Dis Colon Rectum. 1990;33:829–835.
    1. Summers RW, Anuras S, Green J. Jejunal manometry patterns in health, partial intestinal obstruction, and pseudoobstruction. Gastroenterology. 1983;85:1290–1300.
    1. Ducrotte P, Koning E, Guillemot F, Guedon C, Lerebours E, Denis P, Colin R. Jejunal motility during cyclic total parenteral nutrition in patients with Crohn’s disease. Gut. 1989;30:815–819.
    1. Annese V, Bassotti G, Napolitano G, Usai P, Andriulli A, Vantrappen G. Gastrointestinal motility disorders in patients with inactive Crohn’s disease. Scand J Gastroenterol. 1997;32:1107–1117.
    1. Vrees MD, Pricolo VE, Potenti FM, Cao W. Abnormal motility in patients with ulcerative colitis: the role of inflammatory cytokines. Arch Surg. 2002;137:439–445; discussion 445-446.
    1. Neunlist M, Aubert P, Toquet C, Oreshkova T, Barouk J, Lehur PA, Schemann M, Galmiche JP. Changes in chemical coding of myenteric neurones in ulcerative colitis. Gut. 2003;52:84–90.
    1. Cao W, Vrees MD, Kirber MT, Fiocchi C, Pricolo VE. Hydrogen peroxide contributes to motor dysfunction in ulcerative colitis. Am J Physiol Gastrointest Liver Physiol. 2004;286:G833–G843.
    1. Smith AS, Smid SD. Impaired capsaicin and neurokinin-evoked colonic motility in inflammatory bowel disease. J Gastroenterol Hepatol. 2005;20:697–704.
    1. La JH, Kim TW, Sung TS, Kang JW, Kim HJ, Yang IS. Visceral hypersensitivity and altered colonic motility after subsidence of inflammation in a rat model of colitis. World J Gastroenterol. 2003;9:2791–2795.
    1. Verma-Gandhu M, Verdu EF, Bercik P, Blennerhassett PA, Al-Mutawaly N, Ghia JE, Collins SM. Visceral pain perception is determined by the duration of colitis and associated neuropeptide expression in the mouse. Gut. 2007;56:358–364.
    1. Fukudo S. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J Gastroenterol. 2007;42 Suppl 17:48–51.
    1. Choi K, Chen J, Mitra S, Sarna SK. Impaired integrity of DNA after recovery from inflammation causes persistent dysfunction of colonic smooth muscle. Gastroenterology. 2011;141:1293–1301, 1301.e1-3.
    1. Villanacci V, Antonelli E, Geboes K, Casella G, Bassotti G. Histological healing in inflammatory bowel disease: a still unfulfilled promise. World J Gastroenterol. 2013;19:968–978.
    1. Vivinus-Nébot M, Frin-Mathy G, Bzioueche H, Dainese R, Bernard G, Anty R, Filippi J, Saint-Paul MC, Tulic MK, Verhasselt V, et al. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut. 2013:Epub ahead of print.
    1. Bernardini N, Segnani C, Ippolito C, De Giorgio R, Colucci R, Faussone-Pellegrini MS, Chiarugi M, Campani D, Castagna M, Mattii L, et al. Immunohistochemical analysis of myenteric ganglia and interstitial cells of Cajal in ulcerative colitis. J Cell Mol Med. 2012;16:318–327.
    1. Kern F, Almy TP, Abbot FK, Bogdonoff MD. The motility of the distal colon in nonspecific ulcerative colitis. Gastroenterology. 1951;19:492–503.
    1. Spriggs EA, Code CF, Bargen JA, Curtiss RK, Hightower NC. Motility of the pelvic colon and rectum of normal persons and patients with ulcerative colitis. Gastroenterology. 1951;19:480–491.
    1. Connell AM. The motility of the pelvic colon. II. Paradoxical motility in diarrhoea and constipation. Gut. 1962;3:342–348.
    1. Snape WJ, Matarazzo SA, Cohen S. Abnormal gastrocolonic response in patients with ulcerative colitis. Gut. 1980;21:392–396.
    1. Reddy SN, Bazzocchi G, Chan S, Akashi K, Villanueva-Meyer J, Yanni G, Mena I, Snape WJ. Colonic motility and transit in health and ulcerative colitis. Gastroenterology. 1991;101:1289–1297.
    1. Coulie B, Camilleri M, Bharucha AE, Sandborn WJ, Burton D. Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine on colonic motility in patients and healthy subjects. Aliment Pharmacol Ther. 2001;15:653–663.
    1. Bassotti G, de Roberto G, Chistolini F, Sietchiping-Nzepa F, Morelli O, Morelli A. Twenty-four-hour manometric study of colonic propulsive activity in patients with diarrhea due to inflammatory (ulcerative colitis) and non-inflammatory (irritable bowel syndrome) conditions. Int J Colorectal Dis. 2004;19:493–497.
    1. Bassotti G, Gaburri M, Imbimbo BP, Morelli A, Whitehead WE. Distension-stimulated propagated contractions in human colon. Dig Dis Sci. 1994;39:1955–1960.
    1. Bassotti G, Villanacci V, Mazzocchi A, Castellani D, Giuliano V, Corsi S, Morelli A. Colonic propulsive and postprandial motor activity in patients with ulcerative colitis in remission. Eur J Gastroenterol Hepatol. 2006;18:507–510.
    1. Bernstein CN, Niazi N, Robert M, Mertz H, Kodner A, Munakata J, Naliboff B, Mayer EA. Rectal afferent function in patients with inflammatory and functional intestinal disorders. Pain. 1996;66:151–161.
    1. Chrysos E, Athanasakis E, Tsiaoussis J, Zoras O, Nickolopoulos A, Vassilakis JS, Xynos E. Rectoanal motility in Crohn’s disease patients. Dis Colon Rectum. 2001;44:1509–1513.
    1. Mueller MH, Kreis ME, Gross ML, Becker HD, Zittel TT, Jehle EC. Anorectal functional disorders in the absence of anorectal inflammation in patients with Crohn’s disease. Br J Surg. 2002;89:1027–1031.
    1. Andersson P, Olaison G, Hallböök O, Boeryd B, Sjödahl R. Increased anal resting pressure and rectal sensitivity in Crohn’s disease. Dis Colon Rectum. 2003;46:1685–1689.
    1. Kangas E, Hiltunen KM, Matikainen M. Anorectal function in Crohn’s disease. Ann Chir Gynaecol. 1992;81:43–47.
    1. Buchmann P, Kolb E, Alexander-Williams J. Pathogenesis of urgency in defaecation in Crohn’s disease. Digestion. 1981;22:310–316.
    1. Keighley MR, Buchmann P, Lee JR. Assessment of anorectal function in selection of patients for ileorectal anastomosis in Crohn’s colitis. Gut. 1982;23:102–107.
    1. Suzuki H, Fujioka M. Rectal pressure and rectal compliance in ulcerative colitis. Jpn J Surg. 1982;12:79–81.
    1. Rao SS, Read NW, Davison PA, Bannister JJ, Holdsworth CD. Anorectal sensitivity and responses to rectal distention in patients with ulcerative colitis. Gastroenterology. 1987;93:1270–1275.
    1. Loening-Baucke V, Metcalf AM, Shirazi S. Anorectal manometry in active and quiescent ulcerative colitis. Am J Gastroenterol. 1989;84:892–897.
    1. Rao SS, Read NW, Stobart JA, Haynes WG, Benjamin S, Holdsworth CD. Anorectal contractility under basal conditions and during rectal infusion of saline in ulcerative colitis. Gut. 1988;29:769–777.
    1. Arlander E, Löfberg R, Törkvist L, Lindforss U. Exploring anorectal manometry as a method to study the effect of locally administered ropivacaine in patients with ulcerative colitis. ISRN Gastroenterol. 2013;2013:656921.
    1. Heppell J, Taylor BM, Beart RW, Dozois RR, Kelly KA. Predicting outcome after endorectal ileoanal anastomosis. Can J Surg. 1983;26:132–134.
    1. Holdsworth PJ, Sagar PM, Lewis WG, Williamson M, Johnston D. Internal anal sphincter activity after restorative proctocolectomy for ulcerative colitis: a study using continuous ambulatory manometry. Dis Colon Rectum. 1994;37:32–36.
    1. Saigusa N, Belin BM, Choi HJ, Gervaz P, Efron JE, Weiss EG, Nogueras JJ, Wexner SD. Recovery of the rectoanal inhibitory reflex after restorative proctocolectomy: does it correlate with nocturnal continence? Dis Colon Rectum. 2003;46:168–172.
    1. Saigusa N, Kurahashi T, Nakamura T, Sugimura H, Baba S, Konno H, Nakamura S. Functional outcome of stapled ileal pouch-anal canal anastomosis versus handsewn pouch-anal anastomosis. Surg Today. 2000;30:575–581.
    1. Andriesse GI, Gooszen HG, Schipper ME, Akkermans LM, van Vroonhoven TJ, van Laarhoven CJ. Functional results and visceral perception after ileo neo-rectal anastomosis in patients: a pilot study. Gut. 2001;48:683–689.
    1. Rink AD, Kneist W, Radinski I, Guinot-Barona A, Lang H, Vestweber KH. Differences in ano-neorectal physiology of ileoanal and coloanal reconstructions for restorative proctectomy. Colorectal Dis. 2010;12:342–350.
    1. de Zeeuw S, Ahmed Ali U, van der Kolk MB, van Laarhoven KC. Ileal pouch anal anastomosis with close rectal dissection using automated vessel sealers for ulcerative colitis: a promising alternative. Dig Surg. 2011;28:345–351.
    1. Kobayashi Y, Iiai T, Yagi M, Okamoto H, Tani T, Hatakeyama K. Postoperative defecatory function of an ileal pouch-anal anastomosis after a restorative proctocolectomy for ulcerative colitis: evaluation using fecoflowmetry. Int Surg. 2011;96:201–206.
    1. Quigley EM, Bernstein CN. “Irritable bowel symptoms” in inflammatory bowel disease: diagnostic uncertainty meets pathological reality. Am J Gastroenterol. 2012;107:1483–1485.
    1. Rijk MC, van Schaik A, van Tongeren JH. Disposition of mesalazine from mesalazine-delivering drugs in patients with inflammatory bowel disease, with and without diarrhoea. Scand J Gastroenterol. 1992;27:863–868.
    1. Brunner M, Ziegler S, Di Stefano AF, Dehghanyar P, Kletter K, Tschurlovits M, Villa R, Bozzella R, Celasco G, Moro L, et al. Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulation. Br J Clin Pharmacol. 2006;61:31–38.
    1. Lisciandrano D, Benti R, Ranzi T, Baldassarri AR, Bruno A, Bianchi PA, Gerundini P. Scintigraphic imaging and absorption of a 5-aminosalicylic acid enema in patients with ileorectal anastomosis. J Nucl Med. 1999;40:1630–1636.
    1. Wouters MM, Boeckxstaens GE. Neuroimmune mechanisms in functional bowel disorders. Neth J Med. 2011;69:55–61.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir